316 related articles for article (PubMed ID: 7797131)
1. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
[TBL] [Abstract][Full Text] [Related]
2. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases.
Van Laethem JL; Bourgeois V; Parma J; Delhaye M; Cochaux P; Velu T; Devière J; Cremer M
Gastrointest Endosc; 1998 Jun; 47(6):479-85. PubMed ID: 9647372
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions.
Trümper LH; Bürger B; von Bonin F; Hintze A; von Blohn G; Pfreundschuh M; Daus H
Br J Cancer; 1994 Aug; 70(2):278-84. PubMed ID: 8054276
[TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.
Zhou GX; Huang JF; Li ZS; Xu GM; Liu F; Zhang H
World J Gastroenterol; 2004 May; 10(9):1337-40. PubMed ID: 15112354
[TBL] [Abstract][Full Text] [Related]
6. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
[TBL] [Abstract][Full Text] [Related]
7. [Gene diagnosis of pancreatic adenocarcinoma].
Wang ZY; Liu TH; Cui QC
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases.
Pugliese V; Pujic N; Saccomanno S; Gatteschi B; Pera C; Aste H; Ferrara GB; Nicolò G
Gastrointest Endosc; 2001 Nov; 54(5):595-9. PubMed ID: 11677475
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
10. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
[TBL] [Abstract][Full Text] [Related]
12. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
[TBL] [Abstract][Full Text] [Related]
14. Ki-ras oncogene mutations in chronic pancreatitis: which discriminating ability for malignant potential?
van Laethem JL
Ann N Y Acad Sci; 1999 Jun; 880():210-8. PubMed ID: 10415866
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
16. Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma.
Nakamura Y; Onda M; Uchida E
Pancreas; 1999 Mar; 18(2):133-40. PubMed ID: 10090410
[TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
[TBL] [Abstract][Full Text] [Related]
20. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma.
Motojima K; Urano T; Nagata Y; Shiku H; Tsurifune T; Kanematsu T
Ann Surg; 1993 Feb; 217(2):138-43. PubMed ID: 8439212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
